Levels of LCN2 in HCC have been found to positively correlate with 3,3′,5-triiodo-L-thyronine (T3) and its receptor (TR), which led to a study that detected a TR element binding site on LCN2′s promoter [6]. Here, LCN2 is linked to hepatocellular carcinoma.